docetaxel anhydrous has been researched along with Chronic Illness in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Huang, M; Jiang, R; Liu, W; Shi, Y; Wang, T; Yang, M; Zhang, S | 1 |
| Aaltomaa, S; Ahlgren, G; Andrén, O; Brasso, K; Castellanos, E; Damber, JE; de Wit, R; Holmberg, E; Jellvert, Å; Josefsson, A; Luukkaa, M; Meidahl Petersen, P; Seke, M; Verhagen, P; Widmark, A | 1 |
| Everaerts, W; Joniau, S; Van den Broeck, T | 1 |
| Caffo, O; Comploj, E; Fariello, A; Galligioni, E; Sacco, C; Sava, T; Segati, R; Veccia, A; Zustovich, F | 1 |
| Basu, A; Croce, CM; Haldar, S | 1 |
2 trial(s) available for docetaxel anhydrous and Chronic Illness
| Article | Year |
|---|---|
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Disease-Free Survival; Docetaxel; Hormones; Humans; Male; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2023 |
Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chronic Disease; Docetaxel; Estramustine; Humans; Male; Middle Aged; Orchiectomy; Pain; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Taxoids | 2011 |
3 other study(ies) available for docetaxel anhydrous and Chronic Illness
| Article | Year |
|---|---|
Identification of a novel eighteen-gene signature of recurrent metastasis neuroblastoma.
Topics: Chronic Disease; DNA Copy Number Variations; Docetaxel; Gene Expression Profiling; Humans; Neoplasm Recurrence, Local; Neuroblastoma; Vinorelbine | 2023 |
Adjuvant Docetaxel in Nonmetastatic Prostate Cancer: The King Is Dead, Long Live the King!
Topics: Adjuvants, Immunologic; Chronic Disease; Docetaxel; Humans; Male; Prostatic Neoplasms | 2023 |
Bcl2 is the guardian of microtubule integrity.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Chronic Disease; Docetaxel; G2 Phase; Humans; Leukemia; Lymphoma, B-Cell; Male; Microtubules; Paclitaxel; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids; Tumor Cells, Cultured | 1997 |